Not applicableUnknownNCT01588587What this trial is testingDPP-IV Inhibitors Underlying Mechanism of Cancer in Diabetic PatientsWho this might be right forType 2 Diabetes Mellitus Nagaoka Red Cross Hospital 500
Large-scale testing (Phase 3)Study completedNCT04161430What this trial is testingEvaluate the Efficacy and Safety of DBPR108 100 mg in Type 2 Diabetes Mellitus PatientsWho this might be right forType 2 Diabetes Mellitus CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 766
Not applicableUnknownNCT01545024What this trial is testingEffect of DPP-IV Inhibitor on Glycemic Control and Autonomic Neuropathy in Adult Patients With Diabetes MellitusWho this might be right forType 2 Diabetes Mellitus Nagaoka Red Cross Hospital 60
Large-scale testing (Phase 3)Study completedNCT02273050What this trial is testingEvaluate the Efficacy and Safety of Saxagliptin in Combination With Metformin IR Compared to Saxagliptin Monotherapy and to Metformin IR Monotherapy in Drug Naive Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic ControlWho this might be right forType 2 Diabetes Mellitus AstraZeneca 1,136
Large-scale testing (Phase 3)Study completedNCT00918879What this trial is testingEvaluate Saxagliptin in Adult Indian Patients With Type 2 Diabetes Inadequate Glycemic ControlWho this might be right forType 2 Diabetes AstraZeneca 213
Large-scale testing (Phase 3)Study completedNCT01930188What this trial is testingEfficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin and/or TZD in Subjects With Type 2 DiabetesWho this might be right forDiabetesDiabetes Mellitus, Type 2 Novo Nordisk A/S 1,231
Post-approval studies (Phase 4)Not Yet RecruitingNCT07108985What this trial is testingEffect of Add-on SGLT2i, TZD, or Combination Therapy in Type 2 Diabetes Patients on DPP4 InhibitorsWho this might be right forDiabetes Mellitus, Type 2HyperglycemiaInsulin Resistance Yonsei University 100
Early research (Phase 1)Study completedNCT00971659What this trial is testingAdjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 DiabetesWho this might be right forType 2 Diabetes Profil Institut für Stoffwechselforschung GmbH 48
Large-scale testing (Phase 3)Study completedNCT00984867What this trial is testingDapagliflozin DPPIV Inhibitor add-on StudyWho this might be right forType 2 Diabetes AstraZeneca 833
Early research (Phase 1)Study completedNCT03310749What this trial is testingAn Assessment of Pharmacokinetic Gemigliptin and Metformin Interactions in Healthy Mexican VolunteersWho this might be right forDiabetes Mellitus, Type 2 Stendhal Americas, S.A. 34
Post-approval studies (Phase 4)UnknownNCT06449235What this trial is testingReal-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in BangladeshWho this might be right forType2diabetes Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders 938
Not applicableStudy completedNCT02864914What this trial is testingPost-authorisation Safety Study in Patients With Type 2 Diabetes to Assess the Risk of Liver Injury, Kidney Injury, Urinary Tract and Genital Infections, and Diabetic Ketoacidosis in Patients Treated With Empagliflozin, Compared to DPP-4 InhibitorsWho this might be right forDiabetes Mellitus, Type 2 Boehringer Ingelheim 333,580
Post-approval studies (Phase 4)UnknownNCT06164535What this trial is testingThe Effects of DPPIs on Cognitive Function of Diabetic PatientsWho this might be right forCognitive Impairment Beni-Suef University 105
Large-scale testing (Phase 3)Study completedNCT00690638What this trial is testingSafety and Efficacy Study of Dutogliptin/PHX1149T to Treat Type 2 Diabetes MellitusWho this might be right forType 2 Diabetes Mellitus Phenomix 480
Post-approval studies (Phase 4)Study completedNCT00964184What this trial is testingPhenotypic and Genetic Correlates of Diabetes (Non-Type 1) in Young Non-Obese Asian Indians in North India and A Study to Evaluate the Efficacy of Sitagliptin (DPP-4 Inhibitor) in a Sub-group of the Study PopulationWho this might be right forDiabetes Mellitus, Type 2 Diabetes Foundation, India 133
Not applicableStudy completedNCT01677104What this trial is testingThe Microvascular Function of GLP-1 and Its AnaloguesWho this might be right forType 2 DiabetesObesity Katarina Kos 63
Not applicableStudy completedNCT05359341What this trial is testingWhich is Better to Start With DPP-4 Inhibitors or SGLT-2 Inhibitors in Egyptian Diabetic Patients?Who this might be right forDiabete Type 2 Sadat City University 175
Post-approval studies (Phase 4)Study completedNCT02312427What this trial is testingDPP-4 Inhibitor and Serum BNP Level of Diabetic Patients With Congestive Heart FailureWho this might be right forHeart FailureDiabetes Mellitus Mitsui Memorial Hospital 10
Large-scale testing (Phase 3)Study completedNCT01242228What this trial is testingAssess the Safety and Efficacy of ASP1941 in Combination With Dipeptidyl Peptidase-4 (DPP-4) Inhibitor in Type 2 Diabetic PatientsWho this might be right forType 2 Diabetes Mellitus Astellas Pharma Inc 106
Not applicableStudy completedNCT00721552What this trial is testingSitagliptin Prophylaxis for Glucocorticoid-Induced Impairment of Glucose Metabolism in Males With the Metabolic SyndromeWho this might be right forDiabetes MellitusSteroid DiabetesGlucocorticoid-induced Diabetes+1 more Amsterdam UMC, location VUmc 82